Clinical Trials on Intestinal GVHD

Total 15451 results

University of Utah
National Cancer Institute (NCI)

Withdrawn

Exisulind in Preventing Polyps in Patients With Familial Adenomatous Polyposis

Colorectal Cancer | Small Intestine Cancer
Washington University School of Medicine

Active, not recruiting

Defining Predictors of RT Response to Vedolizumab in IBD

Crohn Disease of Small Intestine

United States
Boston Medical Center

Completed

Ganciclovir Plus Arginine Butyrate in Treating Patients With Cancer or Lymphoproliferative Disorders Associated With the Epstein Barr Virus

Lymphoma | Leukemia | Small Intestine Cancer | Precancerous Condition

United States, Italy, Germany, France
Memorial Sloan Kettering Cancer Center
National Cancer Institute (NCI)

Completed

Interferon Alfa-2b in Treating Patients With Advanced Low-Grade Non-Hodgkin's Lymphoma

Lymphoma | Small Intestine Cancer

United States
Medical University of Graz

Recruiting

Study on the Treatment With Water-filtered Infrared-A (wIRA) Radiation in Patients With Morphea and Sclerotic Graft-versus-host Disease

Morphea (Circumscribed Scleroderma) | Sclerotic Graft-versus-host Disease (GVHD)

Austria
Mayo Clinic
National Cancer Institute (NCI)

Completed

Imaging of Radiolabeled White Blood Cells in Patients With Non-Hodgkin's Lymphoma

Lymphoma | Small Intestine Cancer

United States
European Organisation for Research and Treatment...

Completed

Cyclophosphamide, Doxorubicin, Vincristine, and Prednisone With or Without Gemcitabine in Treating Patients With Previously Untreated Aggressive Non-Hodgkin's Lymphoma

Lymphoma | Small Intestine Cancer

France, Belgium, Egypt, Netherlands, Croatia
RenJi Hospital

Not yet recruiting

HFNO Reduces Hypoxia During Sedated Gastroscopy or Colonoscopy in High Risk Patients (HRISK)

Gastritis | Gastric Cancer | Intestinal Cancer | Intestine Adenoma

China
Hospices Civils de Lyon

Unknown

PreOPerative Imaging of NeuroEndocrine Tumors (POPINET)

Small Intestine Cancer | Neuro-endocrine Tumors

France
Sidney Kimmel Comprehensive Cancer Center at Johns...
National Cancer Institute (NCI)

Completed

Azacitidine Plus Phenylbutyrate in Treating Patients With Advanced or Metastatic Solid Tumors That Have Not Responded to Previous Treatment

Lymphoma | Small Intestine Cancer | Unspecified Adult Solid Tumor, Protocol Specific

United States
Astex Pharmaceuticals, Inc.

Completed

Nitrocamptothecin in Treating Patients With Soft Tissue Sarcomas

Sarcoma | Small Intestine Cancer | Gastrointestinal Stromal Tumor

United States
Memorial Sloan Kettering Cancer Center
National Cancer Institute (NCI)

Completed

ZD0473 and Doxorubicin in Treating Patients With Advanced Solid Tumors or Lymphoma

Lymphoma | Small Intestine Cancer | Unspecified Adult Solid Tumor, Protocol Specific

United States
National Cancer Institute (NCI)
Alliance for Clinical Trials in Oncology

Completed

Irinotecan in Treating Patients With Solid Tumors or Lymphoma Who Have Abnormal Liver or Kidney Function or Who Have Received Radiation Therapy to the Pelvis

Lymphoma | Small Intestine Cancer | Unspecified Adult Solid Tumor, Protocol Specific

United States
National Cancer Institute (NCI)

Completed

Rebeccamycin Analog and Cisplatin With or Without Filgrastim in Treating Patients With Advanced Cancer

Lymphoma | Small Intestine Cancer | Unspecified Adult Solid Tumor, Protocol Specific

United States
National Institutes of Health Clinical Center (CC)
National Cancer Institute (NCI)

Completed

CC-5013 in Treating Patients With Cancer That Has Not Responded to Previous Therapy

Lymphoma | Small Intestine Cancer | Unspecified Adult Solid Tumor, Protocol Specific

United States
Institute of Hematology & Blood Diseases Hospital

Not yet recruiting

Ruxolitinib as GVHD Prophylaxis in AA Patients

The Prophylactic Value of Ruxolitinib for aGVHD in HSCT Recipients of AA
University of Jordan

Completed

Growth Hormone (GH) Deficiency & Insulin Like Growth Factor 1 (IGF-I)/ Insulin Like Growth Factor Binding Protein 3 (IGFBP-3) Ratio

Diagnosis of GHD With IGF-I/IGFBP-3 Ratio
National Cancer Institute (NCI)

Completed

BMS-247550 in Treating Patients With Advanced Cancers

Lymphoma | Small Intestine Cancer | Unspecified Adult Solid Tumor, Protocol Specific

United States
NYU Langone Health
National Cancer Institute (NCI)

Completed

PS-341 in Treating Patients With Advanced Solid Tumors or Lymphoma

Lymphoma | Small Intestine Cancer | Unspecified Adult Solid Tumor, Protocol Specific

United States
Dana-Farber Cancer Institute

Completed

Impact of Adnexal Involvement of the Severity and Prognosis of Chronic Graft-versus-Host Disease

Graft vs Host Disease | Chronic Graft vs Host Disease | cGVHD

United States
LG Life Sciences
BioPartners GmbH

Unknown

Treatment of Children With Insufficient Secretion of Growth Hormone (BPLG-004)

Growth Hormone Deficiency (GHD)

United States
University of Wisconsin, Madison
National Cancer Institute (NCI)

Completed

Monoclonal Antibody Therapy in Treating Patients With Refractory Advanced Solid Tumors or Lymphoma

Lymphoma | Small Intestine Cancer | Unspecified Adult Solid Tumor, Protocol Specific

United States
National Institute on Aging (NIA)
National Cancer Institute (NCI)

Completed

Bryostatin 1 and Interleukin-2 in Treating Patients With Refractory Solid Tumors or Lymphoma

Lymphoma | Small Intestine Cancer | Unspecified Adult Solid Tumor, Protocol Specific

United States
Vion Pharmaceuticals

Completed

VNP40101M in Treating Patients With Advanced Solid Tumors or Lymphomas

Lymphoma | Small Intestine Cancer | Unspecified Adult Solid Tumor, Protocol Specific

United States
Fox Chase Cancer Center
National Cancer Institute (NCI)

Completed

Combination Chemotherapy With or Without Biological Therapy in Treating Patients With Refractory Solid Tumor or Lymphoma

Lymphoma | Small Intestine Cancer | Unspecified Adult Solid Tumor, Protocol Specific

United States
University of Oslo

Unknown

Comparison of MR Enteroclysis and MRI With Per Oral Contrast Using a 6 % Mannitol Solution.

Magnetic Resonance Imaging, Intestine Small, Crohn Disease.

Norway
Affiliated Hospital to Academy of Military Medical...

Unknown

Safety and Efficacy of UC-MSC in Patients With Acute Severe Graft-versus-host Disease

Acute GVH Disease

China
University Hospital, Caen

Completed

Perioperative Hemodynamic Optimization Using the Photoplethysmography in Colorectal Surgery (PANEX3)

Colorectal Neoplasms | Crohn Disease | Polyp of Large Intestine

France
Southwest Oncology Group
National Cancer Institute (NCI)

Completed

S0355 Ixabepilone in Treating Patients With Advanced Solid Tumors or Lymphomas and Liver Dysfunction

Lymphoma | Small Intestine Cancer | Unspecified Adult Solid Tumor, Protocol Specific

United States
Societe Internationale d'Oncologie Pediatrique
Children's Cancer and Leukaemia Group; Societe Francaise Oncologie Pediatrique

Completed

Combination Chemotherapy in Treating Children With Metastatic Rhabdomyosarcoma or Other Malignant Mesenchymal Tumors

Sarcoma | Small Intestine Cancer | Ovarian Cancer

France, United Kingdom, Ireland
National Institutes of Health Clinical Center (CC)
National Cancer Institute (NCI)

Completed

17-Dimethylaminoethylamino-17-demethoxygeldanamycin (17-DMAG) in Treating Patients With an Advanced Solid Tumor or Lymphoma

Lymphoma | Small Intestine Cancer | Unspecified Adult Solid Tumor, Protocol Specific

United States
Roswell Park Cancer Institute

Completed

KX2-391 in Treating Patients With Advanced Solid Tumors or Lymphoma That Did Not Respond to Treatment

Lymphoma | Small Intestine Cancer | Unspecified Adult Solid Tumor, Protocol Specific | Lymphoproliferative Disorder

United States
Joseph Antin
Miltenyi Biomedicine GmbH

No longer available

CliniMACS® CD34+ Reagent System for Expanded Access Use

Graft Failure | Delayed Graft Function | Graft-Versus-Host Disease(GVHD) | Anemia Due to Disturbance of Proliferation and/or Differentiation of Hematopoietic Stem Cells

United States
Assistance Publique - Hôpitaux de Paris
Federation Francophone de Cancerologie Digestive; UNICANCER; GERCOR - Multidisciplinary...

Unknown

Colectomy in Patients With Asymptomatic and Unresectable Stage IV Colon Cancer (CLIMAT)

Malignant Neoplasm of Large Intestine | Colon Cancer Liver Metastasis

France
European Organisation for Research and Treatment...

Unknown

Brostallicin or Doxorubicin as First-Line Therapy in Treating Patients With Relapsed, Refractory, or Metastatic Soft Tissue Sarcoma

Sarcoma | Small Intestine Cancer | Ovarian Cancer

Netherlands
Memorial Sloan Kettering Cancer Center
National Cancer Institute (NCI)

Completed

Gemcitabine, Docetaxel, and Filgrastim in Treating Patients With Recurrent or Persistent Leiomyosarcoma or Soft Tissue Sarcoma

Sarcoma | Small Intestine Cancer | Ovarian Cancer

United States
Karolinska University Hospital

Completed

Skin Disease and Pulmonary Mortality After Transplantation

Acute GVH Disease | Pulmonary Mortality
Sun Yat-sen University

Recruiting

Surufatinib and Sintilimab in Combination With Capecitabine for Metastatic Adenocarcinoma of Small Intestine or Appendix Carcinoma

Metastatic | Adenocarcinoma of Small Intestine | Appendix Carcinoma

China
Oslo University Hospital

Completed

Home Care in Allogeneic Haematopoietic Stem Cell Transplantation

Quality of Life | Stem Cell Transplant Complications | GVH - Graft Versus Host Reaction

Norway
Zhejiang University

Completed

Surgery With HIPEC in Treating Patients With a High Risk of Developing Colorectal Peritoneal Carcinomatosis

Peritoneal Carcinomatosis | Malignant Neoplasm of Large Intestine TNM Staging Primary Tumor (T) T4

China
Wake Forest University Health Sciences
National Cancer Institute (NCI)

Completed

Visceral Lymphatic Mapping Using Isosulfan Blue in Patients With Cancer of the Pancreas, Colon, Stomach, Small Intestine, or Gallbladder

Gastric Cancer | Colorectal Cancer | Pancreatic Cancer | Small Intestine Cancer | Gallbladder Cancer

United States
Cancer Research UK

Unknown

Alemtuzumab and Combination Chemotherapy in Treating Patients With Stage I, Stage II, Stage III, or Stage IV Peripheral T-Cell Lymphoma

Lymphoma | Small Intestine Cancer

United Kingdom
Jules Bordet Institute
Macopharma; Belgian Hematological Society

Recruiting

Extracorporeal Photopheresis Using Theraflex ECP™ for Patients With Refractory Chronic Graft Versus Host Disease (cGVHD)

Refractory Chronic Graft Versus Host Disease (cGVHD)

Belgium
University Health Network, Toronto

Completed

Decidual Stromal Cells to Treat Graft-vs-Host Disease After Stem Cell Transplant for Myelodysplastic Syndrome/Myeloproliferative Neoplasm (DSC-SR)

Myelodysplastic/Myeloproliferative Neoplasm | Allogeneic Hematopoietic Cell Transplant | Steroid Refractory GVHD

Canada
University of Zurich

Unknown

Associating Liver Partition With Portal Vein Ligation for Staged Hepatectomy (ALPPS) vs. Two-Stage Hepatectomy (TSH) for Marginally Resectable Colorectal Liver Metastases (CRLM) (ALPPSforCRLM)

Liver Diseases | Liver Neoplasms | Hepatectomy | Surgery | Secondary Malignant Neoplasm of Liver | Colon Cancer Liver Metastases | Malignant Neoplasm of Large Intestine Metastatic to Liver

Switzerland
Vion Pharmaceuticals

Completed

VNP40101M in Treating Patients With Advanced or Metastatic Cancer

Lymphoma | Small Intestine Cancer | Unspecified Adult Solid Tumor, Protocol Specific

United States
Maastricht University Medical Center
Catharina Ziekenhuis Eindhoven

Completed

Questionnaire Study Concerning Artificial Intelligence

Gastro-Intestinal Disorders

Netherlands
University of Nottingham
Northern Care Alliance NHS Foundation Trust; Cambridge University Hospitals... and other collaborators

Recruiting

Pseudo-obstruction Assessment With MRI (POM)

Chronic Intestinal Pseudo-Obstruction

United Kingdom
Sohag University

Recruiting

Evaluation of Intestinal Parasites in Patients With Intestinal Cancer in Sohag, Egypt.

Intestinal Parasites in Patients With Intestinal Cancer

Egypt
Jinling Hospital, China

Completed

Efficacy and Safety of Fecal Microbiota Transplantation for Chronic Intestinal Pseudo-obstruction

Chronic Intestinal Pseudo Obstruction

China

Clinical Trials on Intestinal GVHD

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Norway

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations